Total Payments
$2,579
2024 Payments
$502.96
Companies
23
Transactions
120
Medicare Patients
2,729
Medicare Billing
$170,209
Payment Breakdown by Category
Food & Beverage$2,562 (99.3%)
Gifts$17.20 (0.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,562 | 119 | 99.3% |
| Gift | $17.20 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $498.34 | 21 | $0 (2024) |
| Alcon Vision LLC | $400.35 | 11 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $277.10 | 16 | $0 (2023) |
| Bausch & Lomb Americas Inc. | $213.16 | 10 | $0 (2024) |
| Oyster Point Pharma, Inc. | $188.97 | 8 | $0 (2024) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $187.58 | 8 | $0 (2021) |
| Kala Pharmaceuticals, Inc. | $123.99 | 8 | $0 (2021) |
| Shire North American Group Inc | $118.03 | 6 | $0 (2017) |
| Allergan, Inc. | $90.69 | 4 | $0 (2021) |
| Sun Pharmaceutical Industries Inc. | $70.02 | 4 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $502.96 | 21 | ABBVIE INC. ($240.30) |
| 2023 | $629.95 | 25 | ABBVIE INC. ($210.74) |
| 2022 | $391.83 | 16 | Alcon Vision LLC ($141.13) |
| 2021 | $178.82 | 9 | Bausch & Lomb, a division of Bausch Health US, LLC ($46.83) |
| 2020 | $202.53 | 11 | Kala Pharmaceuticals, Inc. ($76.99) |
| 2019 | $205.03 | 12 | Novartis Pharmaceuticals Corporation ($52.09) |
| 2018 | $181.54 | 9 | Novartis Pharmaceuticals Corporation ($85.44) |
| 2017 | $286.41 | 17 | Shire North American Group Inc ($118.03) |
All Payment Transactions
120 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/08/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: Dry eyes | ||||||
| 10/30/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: EYE CARE | ||||||
| 10/08/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: Ophthalmology | ||||||
| 09/07/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Ophthalmology | ||||||
| 08/29/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: EYE CARE | ||||||
| 08/28/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $26.56 | General |
| Category: Dry eyes | ||||||
| 07/31/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: Ophthalmology | ||||||
| 05/28/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: EYE CARE | ||||||
| 05/22/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $9.60 | General |
| Category: EYE CARE | ||||||
| 05/17/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: Ophthalmology | ||||||
| 05/10/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Dry eyes | ||||||
| 05/07/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: EYE CARE | ||||||
| 04/22/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $122.52 | General |
| Category: EYE CARE | ||||||
| 04/22/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $5.08 | General |
| Category: EYE CARE | ||||||
| 04/15/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $19.41 | General |
| 04/09/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: Inflammation/Rare Disease | ||||||
| 04/08/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: EYE CARE | ||||||
| 03/15/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: Ophthalmology | ||||||
| 02/29/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Inflammation/Rare Disease | ||||||
| 01/26/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: EYE CARE | ||||||
| 01/19/2024 | Alcon Vision LLC | EYSUVIS (Drug) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: Ophthalmology | ||||||
| 12/20/2023 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $7.94 | General |
| Category: EYE CARE | ||||||
| 12/06/2023 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: Ophthalmology | ||||||
| 12/06/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: TEPEZZA | ||||||
| 10/30/2023 | ABBVIE INC. | LUMIGAN (Drug), ALPHAGAN P | Food and Beverage | In-kind items and services | $7.71 | General |
| Category: EYE CARE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 977 | 1,074 | $184,928 | $55,476 |
| 2022 | 8 | 612 | 704 | $124,800 | $38,442 |
| 2021 | 9 | 718 | 826 | $142,068 | $50,318 |
| 2020 | 8 | 422 | 445 | $80,598 | $25,974 |
Total Patients
2,729
Total Services
3,049
Medicare Billing
$170,209
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 283 | 291 | $56,745 | $23,746 | 41.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 146 | 197 | $24,625 | $11,609 | 47.1% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 172 | 206 | $38,728 | $8,665 | 22.4% |
| 92250 | Photography of the retina | Office | 2023 | 146 | 148 | $33,300 | $3,602 | 10.8% |
| 92133 | Imaging of optic nerve | Office | 2023 | 122 | 123 | $15,375 | $2,996 | 19.5% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 26 | 26 | $5,850 | $2,101 | 35.9% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 27 | 28 | $4,060 | $1,618 | 39.9% |
| 92134 | Imaging of retina | Office | 2023 | 34 | 34 | $4,250 | $975.17 | 22.9% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 21 | 21 | $1,995 | $162.36 | 8.1% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 164 | 172 | $33,540 | $14,924 | 44.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 96 | 146 | $18,250 | $7,766 | 42.6% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 92 | 120 | $22,560 | $5,137 | 22.8% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 49 | 49 | $11,025 | $4,214 | 38.2% |
| 92250 | Photography of the retina | Office | 2022 | 113 | 116 | $26,100 | $2,993 | 11.5% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 33 | 35 | $5,075 | $1,873 | 36.9% |
| 92133 | Imaging of optic nerve | Office | 2022 | 49 | 50 | $6,250 | $1,088 | 17.4% |
| 92134 | Imaging of retina | Office | 2022 | 16 | 16 | $2,000 | $447.23 | 22.4% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 166 | 170 | $33,150 | $15,597 | 47.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 117 | 197 | $24,625 | $12,856 | 52.2% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 69 | 69 | $15,525 | $6,821 | 43.9% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 110 | 126 | $23,688 | $5,876 | 24.8% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 58 | 64 | $9,280 | $3,986 | 43.0% |
| 92250 | Photography of the retina | Office | 2021 | 113 | 114 | $25,650 | $3,255 | 12.7% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 45 | 46 | $5,750 | $1,222 | 21.2% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 20 | 20 | $2,500 | $565.99 | 22.6% |
About Dr. Teresa Head, OD
Dr. Teresa Head, OD is a Optometrist healthcare provider based in Coventry, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/13/2008. The National Provider Identifier (NPI) number assigned to this provider is 1851547632.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Teresa Head, OD has received a total of $2,579 in payments from pharmaceutical and medical device companies, with $502.96 received in 2024. These payments were reported across 120 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($2,562).
As a Medicare-enrolled provider, Head has provided services to 2,729 Medicare beneficiaries, totaling 3,049 services with total Medicare billing of $170,209. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Optometrist
- Location Coventry, RI
- Active Since 08/13/2008
- Last Updated 10/14/2025
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1851547632
Products in Payments
- DURYSTA (Drug) $337.21
- Rocklatan (Drug) $246.41
- XIIDRA (Drug) $195.58
- TYRVAYA (Drug) $188.97
- DAILIES (Device) $138.23
- PROLENSA (Drug) $125.51
- INVELTYS (Drug) $123.99
- VYZULTA (Drug) $113.70
- DUREZOL (Drug) $103.23
- LUMIGAN (Drug) $89.52
- TRAVATAN Z (Drug) $79.50
- VUITY (Drug) $71.61
- Omidria (Drug) $55.63
- LOTEMAX SM (Drug) $51.92
- TEPEZZA (Drug) $48.12
- XELPROS (Drug) $47.85
- MIEBO (Drug) $44.05
- ZYLET (Drug) $43.18
- rocklatan (Drug) $42.01
- Simbrinza (Drug) $39.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Coventry
Dr. Richard Liner, Od, OD
Optometrist — Payments: $3,028
Optometrist $3,028
Dr. Thomas Liner, Od, OD
Optometrist — Payments: $1,011
Optometrist $1,011
Liane Prytula, O.d, O.D
Optometrist — Payments: $738.71
Optometrist $738.71
Dr. Mark Blasbalg, O.d, O.D
Optometrist — Payments: $90.00
Optometrist $90.00